“Psoriasis ‘blockbuster’ requires more solid data”, as AbbVie report Risankizumab showed to be more effective in plaque psoriasis patients than J&J’s Stelara Source: AbbVie reports more solid data for would-be psoriasis blockbuster Shared by http://www.pmgrouplive.com/ AbbVie HOME PAGE  >>> www.abbvie.com/